Tano Capital, an alternative asset management firm, recently off-loaded 1,000,000 shares of the oncology active pharmaceutical ingredient manufacturer Shilpa Medicare for a consideration of Rs. 49.8 crore.
Post the sale, Tano Capital’s holding has come down to 8% from 9.3%. The valuation of the company, however, has improved in recent days. While the stock has delivered a return of 30% over a 3-month-period, the stock has been up 19.5% for the past six months and has gained 26.6% over the past year. The stock is currently t